Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Radcliffe Cardiology Confirm PubMed Central Indexing for Interventional Cardiology Review (ICR)

Radcliffe Group Ltd
Posted on: 12 Apr 18
Radcliffe Cardiology Confirm PubMed Central Indexing for Interventional Cardiology Review (ICR)

PR Newswire

LONDON, April 12, 2018

LONDON, April 12, 2018 /PRNewswire/ -- Interventional Cardiology Review (ICR) confirms it has been accepted for indexing on PubMed Central and PubMed.

All articles published under Radcliffe Cardiology's ownership from volumes 8.1 (2013) to 13.1 (2018) are now available in full on this important index, providing greater exposure and scientific validation for the journal and providing greater access for our authors' articles amongst the global cardiology community.

Editor in Chief, DrSimon Kennon says, "I am delighted to add Interventional Cardiology Review (ICR) to Radcliffe Cardiology's journal collection on PubMed and hope this addition helps to serve the wider research community."

ICR provides access to expert opinion and clinical literature reviews through independent, peer-reviewed articles. The journal is led by Editor in Chief, Dr Simon Kennon and is supported by Section Editors, Dr Angela Hoye and Dr Darren Mylotte, as well as an editorial board of world renowned experts.

ICR is the third Radcliffe Cardiology title to be indexed on Pubmed joining Arrhythmia & Electrophysiology Review and Cardiac Failure Review.

For further details please visit: or contact managing Editor:

Related Images

Interventional Cardiology Review (ICR) Cover Image - 13.1
ICR Volume 13, Issue 1, Spring 2018 - Cover Image

Dr. Simon Kennon, Editor in Chief, Interventional Cardiology Review (ICR) Journal
Dr Simon Kennon, is an Interventional Cardiologist and Head of Structural Heart Disease and the Transcatheter Aortic Valve Implantation Programme at the London Chest Hospital, Barts Health NHS Trust, London.

View original content with multimedia:

SOURCE Radcliffe Group Ltd

PR Newswire

Last updated on: 12/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.